Doctor profile · Federal record
Dr. Angela Vediz, PAC
Physician Assistant · Joplin, MO
- NPI 1629066659
- Accepts Medicare
- MIPS 77.9 / 100 · 2023
- 24 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2829 S Jackson Ave
Joplin, MO 648042525
(417) 624-0440
fax (417) 624-9652
Credentials & registration
- NPI registered
- October 2005 — 21 yrs on file
- Profile last updated
- August 8, 2017
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Missouri #2003002304
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1629066659. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,039
Distinct HCPCS
10
Medicare allowed
$265,362
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,229 | 393 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,618 | 1,098 | $71 | |
17000 |
Destruction of precancer skin growth, 1 growth | 748 | 558 | $39 | |
17110 |
Destruction of skin growth, 1-14 growths | 644 | 489 | $85 | |
11102 |
Biopsy of related skin growth, first growth | 172 | 158 | $65 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 103 | 103 | $88 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 88 | 81 | $44 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 68 | 32 | $1 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 62 | 50 | $130 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 59 | 48 | $101 |
In context: peer comparison
Among 8 peers in Joplin Physician Assistant, average services per provider: 141. This provider delivers 43× the peer median.Open Payments
Industry payments received
All-time total
$1,329
Transactions
73
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 16 | $311.83 | |
| Janssen Biotech, INC. | 8 | $243.06 | |
| E.R. Squibb & Sons, L.L.C. | 16 | $154.70 | |
| Genzyme Corporation | 3 | $95.87 | |
| Novartis Pharmaceuticals Corporation | 6 | $95.14 | |
| Lilly USA, LLC | 5 | $80.10 | |
| Dermavant Sciences, INC. | 4 | $69.09 | |
| Ucb, INC. | 3 | $63.14 | |
| Amgen INC. | 3 | $57.78 | |
| Regeneron Healthcare Solutions, INC. | 2 | $42.79 | |
| Mayne Pharma Commercial LLC | 3 | $39.93 | |
| Leo Pharma INC. | 1 | $23.01 | |
| Incyte Corporation | 1 | $20.39 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 1 | $17.62 | |
| Arcutis Biotherapeutics, INC. | 1 | $14.57 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
937
Patients
520
Total drug cost
$33,060
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Doxycycline Hyclate | Generic | 163 | 61 | $4,062 |
| Triamcinolone Acetonide | Generic | 145 | 114 | $2,155 |
| Fluorouracil | Generic | 74 | 63 | $7,593 |
| Clobetasol Propionate | Generic | 73 | 53 | $5,820 |
| Methotrexate (Methotrexate Sodium) | Brand | 65 | 14 | $1,085 |
| Hydroxyzine Hcl | Generic | 61 | 30 | $1,742 |
| Fluconazole | Generic | 54 | 31 | $1,056 |
| Nystatin | Generic | 51 | 33 | $987 |
| Prednisone | Generic | 45 | 40 | $164 |
| Betamethasone Dipropionate | Generic | 43 | 30 | $2,382 |
Frequently asked questions
What is Dr. Angela Vediz's medical specialty?
Dr. Angela Vediz practices Physician Assistant in Joplin, MO.
Where does Dr. Angela Vediz practice?
Dr. Angela Vediz practices at 2829 S Jackson Ave, Joplin, MO 648042525. Office phone: 4176240440.
What is Dr. Angela Vediz's NPI?
Dr. Angela Vediz's National Provider Identifier (NPI) is 1629066659, issued by NPPES.
Does Dr. Angela Vediz accept Medicare assignment?
Yes. Dr. Angela Vediz accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Angela Vediz commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.